blood glucose transition using glucose monitoring system for atrial fibrillation patients undergoing catheter ablation

blood glucose transition using glucose monitoring system for atrial fibrillation patients undergoing catheter ablation - blood glucose transition of atrial fibrillation patients undergoing catheter ablation

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000037847

Enrollment

250

Registered

2019-09-01

Start date

2019-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

A continuous blood glucose recording test using a glucose monitoring system is performed pre and post procedure.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who undergo catheter ablation for atrial fibrillation in our hospital, and who have obtained consent for this study

Exclusion criteria

Exclusion criteria: Patients with dialysis, pregnancy and other implantable medical devices such as pacemakers

Design outcomes

Primary

Measure	Time frame
Evaluation of catheter ablation effect on blood glucose transition for atrial fibrillation	—

Countries

Japan

Contacts

Public ContactDaisetsu Aoyama

Faculty of Medical Sciences, University of Fukui Department of Cardiovascular Medicine

daisetsu@u-fukui.ac.jp0776-61-8800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026